Pharmacyclics LLC et al v. Zydus Worldwide DMCC et al
Plaintiff: Pharmacyclics LLC and Janssen Biotech, Inc.
Defendant: Teva Pharmaceuticals USA, Inc., Zydus Worldwide DMCC, Lek Pharmaceuticals d.d., Cadila Healthcare Limited, Teva Pharmaceutical Industries Ltd. and Sandoz Inc.
Case Number: 1:2018cv00275
Filed: February 16, 2018
Court: US District Court for the District of Delaware
Office: Wilmington Office
County: New Castle
Presiding Judge: Colm F Connolly
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. § 271
Jury Demanded By: Defendant
RSS RSS Track this Docket
Docket Report

This docket was last retrieved on November 26, 2018. A more recent docket listing may be available from PACER.

Date Filed Document Text
November 26, 2018 Opinion or Order ORAL ORDER: Whereas the Court directed the parties during the October 17, 2018 hearing to file a proposed scheduling order using the Court's form order and whereas the parties have not done so, it is hereby ORDERED that the parties shall file by no later than November 29, 2018 a proposed scheduling order using the Court's form order (revised as of November 14, 2018) that incorporates the dates and discovery limitations currently in effect. It is further ORDERED that for all purposes other than trial, these cases are to be treated as consolidated and all filings are to be made in Lead Case No. 18-192-CFC. Signed by Judge Colm F. Connolly on 11/26/2018. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(nmf)
November 26, 2018 Case associated with lead case: Create association to 1:18-cv-00192-CFC. ALL FUTURE FILINGS are to be made in Lead Case No. 18-cv-192-CFC. (nmf)
November 2, 2018 Filing 79 NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian)
October 30, 2018 Opinion or Order Filing 78 PROTECTIVE ORDER. Signed by Judge Colm F. Connolly on 10/29/2018. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(fms)
October 29, 2018 Filing 77 NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants Fresenius Kabi USA LLC, Fresenius Kabi Oncology Limited, Zydus Worldwide DMCC, Cadila Healthcare Limited, Teva Pharmaceuticals USA, Inc., Sandoz Inc., and Lek Pharmaceuticals d.d.'s First Set of Requests for Production of Documents and Things (Nos. 1-99) filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Tigan, Jeremy)
October 26, 2018 Filing 76 PROPOSED ORDER // Protective Order by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Tigan, Jeremy)
October 22, 2018 Filing 75 NOTICE OF SERVICE of Plaintiffs' Responses to Defendants' First Set of Joint Interrogatories (Nos. 1-4) filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Tigan, Jeremy)
October 18, 2018 Opinion or Order ORAL ORDER, Having reviewed the parties' submissions and heard oral argument relating to two disputes over the otherwise agreed-upon protective order (PO) in Civil Actions 18-192-CFC, 18-237-CFC, 18-247-CFC, and 18-275-CFC, IT IS HEREBY ORDERED that Defendants proposal with respect to paragraphs 19 and 20 of the contemplated PO, which would prohibit Plaintiffs from disclosing confidential information (CI) produced to Plaintiffs in discovery by any one Defendant to the outside counsel and experts of any other Defendant without first obtaining the producing Defendants consent, is REJECTED for the reasons stated by the Court and made clear by the Courts questioning of the parties at oral argument on October 17, 2018. The Court further notes that its decision was informed by the following: (1) this action is one of four actions that have been effectively consolidated for pre-trial purposes with a single schedule (including a consolidated Markman hearing) and common discovery; (2) Plaintiffs have proposed a reasonable alternative to Defendants' proposal that would limit the cross-disclosure of CI to Defendants' outside counsel and experts; (3) Defendants agree that their outside counsel are not competitive decision makers and are subject to an agreed-upon prosecution bar in the contemplated PO; (4) the deadline for the parties to identify their respective experts affords each Defendant sufficient time to seek Court intervention in the event a Defendant believes (i) an identified expert is a competitive decision maker or should be subject to the PO's prosecution bar, and/or (ii) good cause exists to prohibit the expert in question from having access to a Defendants CI; (5) Defendants' proposal would place an undue, unfair, and unnecessary burden on Plaintiffs; (6) Defendants' proposal would lead to significant disruptions in discovery, depositions, and court proceedings and would impose an undue burden on the Court; and (7) Defendants have not demonstrated that restrictions beyond Plaintiffs' proposed alternative are necessary to avoid the risk that a co-Defendant would use a producing Defendants' CI's to the competitive disadvantage of the producing Defendant. Ordered by Judge Colm F. Connolly on 10/18/2018. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(nmf)
October 17, 2018 Minute Entry for proceedings held before Judge Colm F. Connolly - Discovery Conference held on 10/17/2018. (Court Reporter V. Gunning.) Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(nmf)
October 16, 2018 Filing 74 Letter to The Honorable Colm F. Connolly from Jeremy A. Tigan regarding the proposed Protective Order - re (45 in 1:18-cv-00192-CFC, 39 in 1:18-cv-00247-CFC, 57 in 1:18-cv-00237-CFC, 73 in 1:18-cv-00275-CFC) Letter. (Attachments: #1 Exhibits A-D)(Tigan, Jeremy)
October 15, 2018 Filing 73 Letter to The Honorable Colm F. Connolly from Dominick T. Gattuso regarding Opening Discovery Dispute Letter. (Attachments: #1 Exhibit A, #2 Exhibit B)(Gattuso, Dominick)
October 12, 2018 Filing 72 NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions filed by Janssen Biotech, Inc., Pharmacyclics LLC.(Tigan, Jeremy)
October 9, 2018 Opinion or Order SO ORDERED, re (71 in 1:18-cv-00275-CFC, 44 in 1:18-cv-00192-CFC, 55 in 1:18-cv-00237-CFC) STIPULATION TO EXTEND TIME to EXTEND the deadline for Defendants' Initial Invalidity Contentions to 11/2/2018 filed by Fresenius Kabi USA, LLC, (38 in 1:18-cv-00247-CFC) STIPULATION TO EXTEND TIME to Extend Deadline for Initial Invalidity Contentions to November 2, 2018 filed by Cipla Limited, Cipla USA Inc.. Signed by Judge Colm F. Connolly on 10/9/2018. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(fms)
October 5, 2018 Filing 71 STIPULATION TO EXTEND TIME to EXTEND the deadline for Defendants' Initial Invalidity Contentions to 11/2/2018 - filed by Fresenius Kabi USA, LLC. (Farnan, Brian)
October 3, 2018 Set Hearings: A Discovery Conference is set for 10/17/2018 at 11:00 AM per request of counsel in Courtroom 4B before Judge Colm F. Connolly. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(nmf)
October 1, 2018 Opinion or Order Filing 70 ORDER: IT IS ORDERED that on or before October 22, 2018, each party or each party group shall email to Chief Magistrate Judge Thynge, with a copy to her Judicial Administrator, Cathleen Kennedy, information requested regarding ADR. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 10/1/18. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(cak)
September 20, 2018 Pro Hac Vice Attorney Hershy Stern,Jay R. Deshmukh for Cadila Healthcare Limited, Zydus Worldwide DMCC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
September 20, 2018 Case reassigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC (rjb)
September 19, 2018 Opinion or Order SO ORDERED - re #69 MOTION for Pro Hac Vice Appearance of Attorney Jay R. Deshmukh and Hershy Stern of Kasowitz Benson Torres LLP filed by Zydus Worldwide DMCC, Cadila Healthcare Limited. Ordered by Judge Gregory M. Sleet on 9/19/2018. (mdb)
September 18, 2018 Filing 69 MOTION for Pro Hac Vice Appearance of Attorney Jay R. Deshmukh and Hershy Stern of Kasowitz Benson Torres LLP - filed by Cadila Healthcare Limited, Zydus Worldwide DMCC. (Palapura, Bindu)
September 18, 2018 Filing 68 NOTICE requesting Clerk to remove Richard J. Berman, Janine A. Carlan, Bradford C. Frese, Taniel Anderson and Gary A. Coad of Arent Fox LLP as co-counsel. Reason for request: no longer working on case. (Palapura, Bindu)
September 18, 2018 Filing 67 NOTICE of Joinder in Defendants Fresenius Kabi's, Zydus's, Teva's, Sun's, and Cipla's First Set of Joint Interrogatories to Plaintiffs (Nos. 1-4) served on September 7, 2018 in C.A. Nos. 18-192 (GMS), 18-275 (GMS), 18-237 (GMS) and 18-247(GMS); and (ii) Defendants Fresenius Kabi's, Zydus's and Teva's First Set of Requests for Production of Documents and Things to Plaintiffs (1-99) by Lek Pharmaceuticals d.d., Sandoz Inc. re #64 Notice of Service, #65 Notice of Service (Gattuso, Dominick)
September 13, 2018 Filing 66 NOTICE requesting Clerk to remove Jay R. Deshmukh as co-counsel. Reason for request: no longer with the firm of Arent Fox LLP. (Palapura, Bindu)
September 7, 2018 Filing 65 NOTICE OF SERVICE of Fresenius Kabi's, Zydus's, and Teva's First Set of Requests for Production of Documents and Things to Plaintiffs (Nos. 1-99) filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian)
September 7, 2018 Filing 64 NOTICE OF SERVICE of Fresenius Kabi's, Zydus's, Sun's, Cipla's and Teva's First Set of Joint Interrogatories to Plaintiffs (Nos. 1-4) filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian)
September 5, 2018 Filing 63 NOTICE OF SERVICE of 1) Plaintiffs' Initial Infringement Contentions (as to Defendants Zydus Worldwide DMCC and Cadila Healthcare Limited) and 2) Plaintiffs' Initial Infringement Contentions (as to Defendants Sandoz Inc. and Lek Pharmaceuticals d.d.) filed by Janssen Biotech, Inc., Pharmacyclics LLC.(Blumenfeld, Jack)
September 5, 2018 Filing 62 NOTICE OF SERVICE of Zydus Defendants' Responses and Objections to Plaintiffs' First Set of Requests (Nos. 1-11) for the Production of Documents and Things (Confidential) filed by Cadila Healthcare Limited, Zydus Worldwide DMCC.(Moore, David)
September 5, 2018 Filing 61 NOTICE OF SERVICE of Defendants Sandoz Inc. and Lek Pharmaceuticals d.d.'s Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things [CONFIDENTIAL] filed by Lek Pharmaceuticals d.d., Sandoz Inc..(Gattuso, Dominick)
September 5, 2018 Filing 60 NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.'s Responses to Plaintiffs' First Set of Requests (Nos. 1-11) to Teva Pharmaceuticals USA, Inc. for the Production of Documents and Things filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen)
August 29, 2018 Opinion or Order SO ORDERED - re (33 in 1:18-cv-00247-GMS, 59 in 1:18-cv-00275-GMS, 37 in 1:18-cv-00192-GMS, 48 in 1:18-cv-00237-GMS) STIPULATION TO EXTEND TIME for the parties to submit their Protective Order to September 7, 2018 filed by Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 8/29/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb)
August 27, 2018 Filing 59 STIPULATION TO EXTEND TIME for the parties to submit their Protective Order to September 7, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC. (Blumenfeld, Jack)
August 22, 2018 Opinion or Order SO ORDERED - re (31 in 1:18-cv-00247-GMS, 57 in 1:18-cv-00275-GMS, 46 in 1:18-cv-00237-GMS, 35 in 1:18-cv-00192-GMS) STIPULATION TO EXTEND TIME for the parties to submit their protective order to August 20, 2018 filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC, (58 in 1:18-cv-00275-GMS, 32 in 1:18-cv-00247-GMS, 36 in 1:18-cv-00192-GMS, 47 in 1:18-cv-00237-GMS) STIPULATION TO EXTEND TIME for the parties to submit their Protective Order to August 27, 2018 filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 8/22/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb)
August 20, 2018 Filing 58 STIPULATION TO EXTEND TIME for the parties to submit their Protective Order to August 27, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Blumenfeld, Jack)
August 13, 2018 Filing 57 STIPULATION TO EXTEND TIME for the parties to submit their protective order to August 20, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Blumenfeld, Jack)
August 6, 2018 Filing 56 NOTICE OF SERVICE of (1) Plaintiffs' First Set of Requests (Nos. 1-11) to Teva Pharmaceuticals USA, Inc. for the Production of Documents and Things; (2) Plaintiffs' First Set of Requests (Nos. 1-11) to Zydus Worldwide DMCC and Cadila Healthcare Limited for the Production of Documents and Things; and (3) Plaintiffs' First Set of Requests (Nos. 1-11) to Sandoz Inc. and Lek Pharmaceuticals D.D. for the Production of Documents and Things filed by Janssen Biotech, Inc., Pharmacyclics LLC.(Blumenfeld, Jack)
July 31, 2018 Opinion or Order SO ORDERED - re (55 in 1:18-cv-00275-GMS, 44 in 1:18-cv-00237-GMS, 29 in 1:18-cv-00247-GMS, 33 in 1:18-cv-00192-GMS) STIPULATION TO EXTEND TIME for the parties to submit the Protective Order to August 13, 2018 filed by Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 7/31/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb)
July 27, 2018 Filing 55 STIPULATION TO EXTEND TIME for the parties to submit the Protective Order to August 13, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC. (Noreika, Maryellen)
July 20, 2018 CASE REFERRED to Chief Magistrate Judge Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at # http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(fms)
July 18, 2018 Filing 54 NOTICE OF SERVICE of Sandoz Inc.'s Production of Core Technical Documents Bearing Bates Numbers SANDOZIBRUT00000001 to SANDOZIBRUT00026328 [HIGHLY CONFIDENTIAL, OUTSIDE COUNSEL EYES ONLY] filed by Sandoz Inc..(Gattuso, Dominick)
July 18, 2018 Filing 53 NOTICE of Withdrawal of Attorney Carolina Veltri by Lek Pharmaceuticals d.d., Sandoz Inc. (Gattuso, Dominick)
July 9, 2018 Filing 52 NOTICE OF SERVICE of Defendants Sandoz Inc.'s and Lek Pharmaceutical d.d.'s (1) Paragraph 3 Initial Disclosures, and (2) Rule 26(a)(1) Initial Disclosures filed by Lek Pharmaceuticals d.d., Sandoz Inc..(Gattuso, Dominick)
July 5, 2018 Filing 51 ANSWER to #27 Answer to Complaint, Counterclaim by Janssen Biotech, Inc., Pharmacyclics LLC.(Blumenfeld, Jack)
July 2, 2018 Filing 50 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Lek Pharmaceuticals d.d. filed by Lek Pharmaceuticals d.d.. (Gattuso, Dominick)
July 2, 2018 Filing 49 ANSWER to #1 Complaint, with Jury Demand by Lek Pharmaceuticals d.d..(Gattuso, Dominick)
June 29, 2018 Opinion or Order SO ORDERED - re (40 in 1:18-cv-00237-GMS, 28 in 1:18-cv-00247-GMS, 48 in 1:18-cv-00275-GMS, 32 in 1:18-cv-00192-GMS) Proposed Scheduling Order: Cases referred to the Magistrate Judge for the purpose of exploring ADR. (Motions for Joinder of Parties and to Amended Pleadings due by 8/16/2019., Claim Construction Opening Briefs due by 3/15/2019., Claim Construction Answering Briefs due by 4/19/2019., A Markman Hearing (full day) is set for 5/20/2019 at 09:30 AM in Courtroom 4A., Fact Discovery completed by 11/15/2019., Opening Expert Reports due by 2/7/2020., Rebuttal Expert Reports due by 3/27/2020., Expert Discovery due by 5/22/2020., A Status Telephone Conference is set for 3/9/2020 at 10:00 AM to discuss the length of trial and consolidation., Proposed Final Pretrial Order due by 7/31/2020., A Final Pretrial Conference is set for 8/10/2020 at 10:00 AM in Courtroom 4A., A Bench Trial (Length TBD) is set for 9/14/2020 at 09:00 AM in Courtroom 4A. See Proposed Scheduling Order for more details). Ordered by Judge Gregory M. Sleet on 6/29/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb)
June 28, 2018 Filing 48 PROPOSED ORDER -- Scheduling Order -- by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Attachments: #1 Letter to The Honorable Gregory M. Sleet)(Blumenfeld, Jack)
June 27, 2018 Opinion or Order SO ORDERED - re #46 STIPULATION TO EXTEND TIME to Answer Complaint to July 2, 2018 filed by Lek Pharmaceuticals d.d. Set/Reset Answer Deadlines: Lek Pharmaceuticals d.d. answer due 7/2/2018. Ordered by Judge Gregory M. Sleet on 6/27/2018. (mdb)
June 25, 2018 Filing 47 NOTICE OF SERVICE of (1) Paragraph 3 Disclosures of Defendant Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen)
June 25, 2018 Filing 46 STIPULATION TO EXTEND TIME to Answer Complaint to July 2, 2018 - filed by Lek Pharmaceuticals d.d.. (Gattuso, Dominick)
June 18, 2018 Filing 45 NOTICE OF SERVICE of Plaintiffs' Paragraph 3 Initial Disclosures filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Blumenfeld, Jack)
June 18, 2018 Filing 44 NOTICE OF SERVICE of Defendants Zydus Worldwide and Cadila Healthcare's Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Cadila Healthcare Limited, Zydus Worldwide DMCC.(O'Byrne, Stephanie)
June 15, 2018 Filing 43 Official Transcript of Telephone Conference held on 06 14 18 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 7/6/2018. Redacted Transcript Deadline set for 7/16/2018. Release of Transcript Restriction set for 9/13/2018. (kjm)
June 14, 2018 CORRECTING ENTRY: The Minute Entry dated today has been corrected to reflect that the Final Pretrial Conference is set for 8/10/2020 at 10:00 AM in Courtroom 4A. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb)
June 14, 2018 Minute Entry for proceedings held before Judge Gregory M. Sleet - Telephone Scheduling Conference held on 6/14/2018. The court assigned the following deadlines: The Markman Hearing (full day) is set for 5/20/2019 at 9:30 AM in Courtroom 4A; a Telephone Conference, to discuss the length of trial and consolidation, is set for 3/9/2020 at 10:00 AM; the Final Proposed Pretrial Order is due by the close of business on 7/31/2020; the Final Pretrial Conference is set for 8/10/2020 at 10:00 AM in Courtroom 4A; and the Bench Trial (length TBD) is set for 9/14/2020 at 9:00 AM in Courtroom 4A. The cases are referred to the Magistrate Judge for exploring ADR. An amended proposed scheduling order is due by 6/28/2018. The parties shall work out the rest of the schedule, given the dates and orders provided. (Court Reporter Kevin Maurer.) Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) Modified on 6/14/2018 (mdb).
June 6, 2018 Opinion or Order ORAL ORDER re (31 in 1:18-cv-00237-GMS, 37 in 1:18-cv-00275-GMS, 26 in 1:18-cv-00192-GMS, 22 in 1:18-cv-00247-GMS) Joint Status Report - A Scheduling Telephone Conference is set for 6/14/2018 at 02:00 PM before Judge Gregory M. Sleet. The plaintiffs shall arrange the call and contact Chambers at (32) 573-4559 once all parties are on the line. Ordered by Judge Gregory M. Sleet on 6/6/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb)
June 5, 2018 Filing 42 NOTICE OF SERVICE of (1) Plaintiffs Pharmacyclics LLC and Janssen Biotech, Inc.'s Initial Disclosures Pursuant to Rule 26(a)(1) and (2) Plaintiffs Pharmacyclics LLC and Janssen Biotech, Inc.'s Identification of Accused Products and Asserted Patents filed by Pharmacyclics LLC, Janssen Biotech Inc..(Blumenfeld, Jack)
June 5, 2018 Filing 41 NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC and Cadila Healthcare Limited's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Cadila Healthcare Limited, Zydus Worldwide DMCC.(Moore, David)
June 5, 2018 Filing 40 NOTICE OF SERVICE of Initial Disclosures of Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen)
May 29, 2018 Filing 39 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Sandoz Inc. filed by Sandoz Inc.. (Gattuso, Dominick)
May 29, 2018 Filing 38 ANSWER to #1 Complaint, with Jury Demand by Sandoz Inc..(Gattuso, Dominick)
May 25, 2018 Filing 37 Joint STATUS REPORT by Janssen Biotech, Inc., Pharmacyclics LLC. (Attachments: #1 Proposed Schedulng Order)(Blumenfeld, Jack)
May 24, 2018 Opinion or Order SO ORDERED - re (35 in 1:18-cv-00275-GMS, 25 in 1:18-cv-00192-GMS, 29 in 1:18-cv-00237-GMS, 21 in 1:18-cv-00247-GMS) STIPULATION TO EXTEND TIME for the parties to submit the joint status report and proposed scheduling order to May 25, 2018 filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 5/24/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb)
May 24, 2018 Opinion or Order SO ORDERED - re #36 STIPULATION TO EXTEND TIME for Plaintiffs to move, answer, or otherwise respond to Teva's counterclaims to July 5, 2018 filed by Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 5/24/2018. (mdb)
May 23, 2018 Filing 36 STIPULATION TO EXTEND TIME for Plaintiffs to move, answer, or otherwise respond to Teva's counterclaims to July 5, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC. (Blumenfeld, Jack)
May 23, 2018 Pro Hac Vice Attorney Carolina Veltri,Natalie C. Clayton,Siraj M. Abhyankar for Lek Pharmaceuticals d.d., Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
May 22, 2018 Filing 35 STIPULATION TO EXTEND TIME for the parties to submit the joint status report and proposed scheduling order to May 25, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Noreika, Maryellen)
May 21, 2018 Opinion or Order SO ORDERED - re #34 MOTION for Pro Hac Vice Appearance of Attorney Natalie C. Clayton, Siraj M. Abhyankar and Carolina Veltri filed by Lek Pharmaceuticals d.d., Sandoz Inc.. Ordered by Judge Gregory M. Sleet on 5/21/2018. (mdb)
May 18, 2018 Filing 34 MOTION for Pro Hac Vice Appearance of Attorney Natalie C. Clayton, Siraj M. Abhyankar and Carolina Veltri - filed by Lek Pharmaceuticals d.d., Sandoz Inc.. (Gattuso, Dominick)
May 18, 2018 Opinion or Order SO ORDERED - re (28 in 1:18-cv-00237-GMS, 24 in 1:18-cv-00192-GMS, 33 in 1:18-cv-00275-GMS, 20 in 1:18-cv-00247-GMS) MOTION for Pro Hac Vice Appearance of Attorney Nicole A. Conlon filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 5/18/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb)
May 18, 2018 Opinion or Order SO ORDERED - re #32 Stipulation filed by Lek Pharmaceuticals d.d., Set/Reset Answer Deadlines: Lek Pharmaceuticals d.d. answer due 6/25/2018.. Ordered by Judge Gregory M. Sleet on 5/18/2018. (mdb)
May 17, 2018 Filing 33 MOTION for Pro Hac Vice Appearance of Attorney Nicole A. Conlon - filed by Janssen Biotech, Inc. (Noreika, Maryellen) Modified on 5/17/2018 (ceg).
May 17, 2018 Filing 32 STIPULATION and [Proposed] Order Regarding Service of Process on Defendant Lek Pharmaceuticals d.d. and Extension of Time for Defendant Lek Pharmaceutical d.d. to Respond to the Complaint by Lek Pharmaceuticals d.d.. (Gattuso, Dominick)
May 15, 2018 Opinion or Order SO ORDERED - re #31 STIPULATION TO EXTEND TIME to Answer Complaint to May 29, 2018 filed by Sandoz Inc., Set/Reset Answer Deadlines: Sandoz Inc. answer due 5/29/2018.. Ordered by Judge Gregory M. Sleet on 5/15/2018. (mdb)
May 15, 2018 Opinion or Order SO ORDERED - re (26 in 1:18-cv-00237-GMS, 18 in 1:18-cv-00247-GMS, 30 in 1:18-cv-00275-GMS, 23 in 1:18-cv-00192-GMS) STIPULATION TO EXTEND TIME for the parties to submit the Joint Status Report and proposed scheduling order to May 22, 2018 filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 5/15/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb)
May 14, 2018 Filing 31 STIPULATION TO EXTEND TIME to Answer Complaint to May 29, 2018 - filed by Sandoz Inc.. (Gattuso, Dominick)
May 14, 2018 Filing 30 STIPULATION TO EXTEND TIME for the parties to submit the Joint Status Report and proposed scheduling order to May 22, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Blumenfeld, Jack)
May 10, 2018 Opinion or Order SO ORDERED - re #29 STIPULATION TO EXTEND TIME for Plaintiffs to move, answer, or otherwise respond to Teva's counterclaims to June 4, 2018 filed by Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 5/10/2018. (mdb)
May 9, 2018 Filing 29 STIPULATION TO EXTEND TIME for Plaintiffs to move, answer, or otherwise respond to Teva's counterclaims to June 4, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC. (Blumenfeld, Jack)
April 23, 2018 Filing 28 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen)
April 23, 2018 Filing 27 ANSWER to #1 Complaint, , COUNTERCLAIM against Janssen Biotech, Inc., Pharmacyclics LLC by Teva Pharmaceuticals USA, Inc..(Keller, Karen)
April 23, 2018 CORRECTING ENTRY: The Disclosure Statement (formerly DI 28) has been removed from the docket per request from the filer. (mdb)
April 19, 2018 Pro Hac Vice Attorney Richard J. Berman, Gary A. Coad, Taniel E. Anderson, Jay R. Deshmukh, Bradford C. Frese, and Janine A. Carlan for Zydus Worldwide DMCC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg)
April 18, 2018 Opinion or Order SO ORDERED - re #26 MOTION for Pro Hac Vice Appearance of Attorney Jay R. Deshmukh, Richard J. Berman, Janine A. Carlan, Bradford C. Frese, Taniel E. Anderson and Gary A. Coad of Arent Fox LLP filed by Zydus Worldwide DMCC, Cadila Healthcare Limited. Ordered by Judge Gregory M. Sleet on 4/18/2018. (mdb)
April 16, 2018 Filing 26 MOTION for Pro Hac Vice Appearance of Attorney Jay R. Deshmukh, Richard J. Berman, Janine A. Carlan, Bradford C. Frese, Taniel E. Anderson and Gary A. Coad of Arent Fox LLP - filed by Cadila Healthcare Limited, Zydus Worldwide DMCC. (Palapura, Bindu)
April 13, 2018 Opinion or Order SO ORDERED - re (22 in 1:18-cv-00192-GMS, 25 in 1:18-cv-00275-GMS, 20 in 1:18-cv-00237-GMS, 13 in 1:18-cv-00247-GMS) STIPULATION TO EXTEND TIME to Submit Joint Status Report and Proposed Scheduling Order to May 15, 2018 filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 4/13/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb)
April 12, 2018 Filing 25 STIPULATION TO EXTEND TIME to Submit Joint Status Report and Proposed Scheduling Order to May 15, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Blumenfeld, Jack)
April 11, 2018 Filing 24 MOTION for Pro Hac Vice Appearance of Attorney Gregory L. Diskant, Irena Royzman, Jordan M. Engelhardt, and Lachlan Campbell-Verduyn - filed by Janssen Biotech, Inc.. (Blumenfeld, Jack)
April 11, 2018 Opinion or Order SO ORDERED - re (21 in 1:18-cv-00192-GMS, 24 in 1:18-cv-00275-GMS, 12 in 1:18-cv-00247-GMS) MOTION for Pro Hac Vice Appearance of Attorney Gregory L. Diskant, Irena Royzman, Jordan M. Engelhardt, and Lachlan Campbell-Verduyn filed by Janssen Biotech, Inc.. Ordered by Judge Gregory M. Sleet on 4/11/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb)
April 10, 2018 Opinion or Order Filing 23 SO ORDERED - re #22 Stipulation of Dismissal Dismissing Defendant Teva Pharmaceutical Industries Ltd. Without Prejudice And Amending Caption To Reflect Same. Party Teva Pharmaceutical Industries Ltd. terminated.. Signed by Judge Gregory M. Sleet on 4/10/2018. (mdb)
April 6, 2018 Filing 22 STIPULATION of Dismissal Dismissing Defendant Teva Pharmaceutical Industries Ltd. Without Prejudice And Amending Caption To Reflect Same by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Keller, Karen) Modified on 4/6/2018 (mdb).
April 5, 2018 Filing 21 ANSWER to #15 Answer to Complaint, Counterclaim by Janssen Biotech, Inc., Pharmacyclics LLC.(Noreika, Maryellen)
April 5, 2018 Opinion or Order SO ORDERED - re (19 in 1:18-cv-00192-GMS, 11 in 1:18-cv-00247-GMS, 13 in 1:18-cv-00237-GMS, 20 in 1:18-cv-00275-GMS) MOTION for Pro Hac Vice Appearance of Attorney Christopher N. Sipes, Erica N. Andersen, Brianne Bharkhda, and Nicholas L. Evoy filed by Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 4/5/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb)
April 3, 2018 Filing 20 MOTION for Pro Hac Vice Appearance of Attorney Christopher N. Sipes, Erica N. Andersen, Brianne Bharkhda, and Nicholas L. Evoy - filed by Pharmacyclics LLC. (Blumenfeld, Jack)
March 23, 2018 Filing 19 WAIVER OF SERVICE returned executed by Janssen Biotech, Inc., Pharmacyclics LLC: For Sandoz Inc. waiver sent on 3/22/2018, answer due 5/21/2018. (Noreika, Maryellen)
March 23, 2018 Filing 18 REQUEST FOR WAIVER of Service sent to Sandoz Inc. on 3/22/2018 by Janssen Biotech, Inc., Pharmacyclics LLC. Waiver of Service due by 4/23/2018. (Noreika, Maryellen)
March 19, 2018 Opinion or Order Filing 17 ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 3/19/2018. (asw)
March 15, 2018 Filing 16 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Cadila Healthcare Limited for Zydus Worldwide DMCC; Corporate Parent none for Cadila Healthcare Limited filed by Cadila Healthcare Limited, Zydus Worldwide DMCC. (Moore, David)
March 15, 2018 Filing 15 ANSWER to #1 Complaint, , COUNTERCLAIM against Janssen Biotech, Inc., Pharmacyclics LLC by Zydus Worldwide DMCC, Cadila Healthcare Limited.(Moore, David)
March 15, 2018 Opinion or Order SO ORDERED - re #14 MOTION for Pro Hac Vice Appearance of Attorney Helena Berezowskyj and Rhiannon I. D'Agostin filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. Ordered by Judge Gregory M. Sleet on 3/15/2018. (mdb)
March 15, 2018 Pro Hac Vice Attorney Rhiannon I. D'Agostin,Helena Berezowskyj for Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
March 14, 2018 Filing 14 MOTION for Pro Hac Vice Appearance of Attorney Helena Berezowskyj and Rhiannon I. D'Agostin - filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Keller, Karen)
March 8, 2018 Opinion or Order SO ORDERED - re #13 MOTION for Pro Hac Vice Appearance of Attorney Gary E. Hood, Luke T. Shannon and Mark T. Deming filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. Ordered by Judge Gregory M. Sleet on 3/8/2018. (mdb)
March 8, 2018 Pro Hac Vice Attorney Gary E. Hood,Luke T. Shannon,Mark T. Deming for Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
March 6, 2018 Filing 13 MOTION for Pro Hac Vice Appearance of Attorney Gary E. Hood, Luke T. Shannon and Mark T. Deming - filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan)
February 26, 2018 Filing 12 SUMMONS Returned Executed by Pharmacyclics LLC, Janssen Biotech, Inc.. Zydus Worldwide DMCC served on 2/22/2018, answer due 3/15/2018. (Blumenfeld, Jack)
February 26, 2018 Filing 11 SUMMONS Returned Executed by Pharmacyclics LLC, Janssen Biotech, Inc.. Cadila Healthcare Limited served on 2/22/2018, answer due 3/15/2018. (Blumenfeld, Jack)
February 26, 2018 Filing 10 WAIVER OF SERVICE returned executed by Pharmacyclics LLC, Janssen Biotech, Inc.: For Teva Pharmaceuticals USA, Inc. waiver sent on 2/20/2018, answer due 4/23/2018. (Blumenfeld, Jack)
February 26, 2018 Filing 9 REQUEST FOR WAIVER of Service sent to Teva Pharmaceuticals USA, Inc. on 2/20/2018 by Janssen Biotech, Inc., Pharmacyclics LLC. Waiver of Service due by 3/22/2018. (Blumenfeld, Jack)
February 21, 2018 Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. (nms)
February 16, 2018 Filing 8 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Biotech, Inc. filed by Janssen Biotech, Inc. (crb)
February 16, 2018 Filing 7 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AbbVie Inc. for Pharmacyclics LLC filed by Pharmacyclics LLC. (crb)
February 16, 2018 Filing 6 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See Attachment. (crb)
February 16, 2018 Filing 5 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/4/18. Date of Expiration of Patent: See Attachment.Thirty Month Stay Deadline: 5/13/2021. (crb)
February 16, 2018 Filing 4 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/5/18. Date of Expiration of Patent: See Attachment.Thirty Month Stay Deadline: 5/13/2021. (crb)
February 16, 2018 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/4/18. Date of Expiration of Patent: See Attachment.Thirty Month Stay Deadline: 5/13/2021. (crb)
February 16, 2018 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (crb)
February 16, 2018 Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Cadila Healthcare Limited, Lek Pharmaceuticals d.d., Sandoz Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Zydus Worldwide DMCC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2324796.) - filed by Pharmacyclics LLC, Janssen Biotech, Inc. (Attachments: #1 Exhibit A - Q, #2 Exhibit R - T, #3 Civil Cover Sheet)(crb)
February 16, 2018 Summons Issued with Magistrate Consent Notice attached as to Cadila Healthcare Limited on 2/16/2018; Lek Pharmaceuticals d.d. on 2/16/2018; Sandoz Inc. on 2/16/2018; Teva Pharmaceutical Industries Ltd. on 2/16/2018; Teva Pharmaceuticals USA, Inc. on 2/16/2018; Zydus Worldwide DMCC on 2/16/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (crb)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Pharmacyclics LLC et al v. Zydus Worldwide DMCC et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Teva Pharmaceuticals USA, Inc.
Represented By: Karen Elizabeth Keller
Represented By: Mark T. Deming
Represented By: Luke T. Shannon
Represented By: Helena Berezowskyj
Represented By: Gary E. Hood
Represented By: Rhiannon I. D'Agostin
Represented By: Nathan Roger Hoeschen
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Zydus Worldwide DMCC
Represented By: Hershy Stern
Represented By: Bindu Ann George Palapura
Represented By: Richard J. Berman
Represented By: Janine A. Carlan
Represented By: Taniel E. Anderson
Represented By: David Ellis Moore
Represented By: Bradford C. Frese
Represented By: Gary A. Coad
Represented By: Jay R. Deshmukh
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Lek Pharmaceuticals d.d.
Represented By: Siraj M. Abhyankar
Represented By: Carolina Veltri
Represented By: Natalie C. Clayton
Represented By: Dominick T. Gattuso
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Cadila Healthcare Limited
Represented By: Hershy Stern
Represented By: Bindu Ann George Palapura
Represented By: David Ellis Moore
Represented By: Jay R. Deshmukh
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Teva Pharmaceutical Industries Ltd.
Represented By: Karen Elizabeth Keller
Represented By: Mark T. Deming
Represented By: Luke T. Shannon
Represented By: Gary E. Hood
Represented By: Nathan Roger Hoeschen
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Sandoz Inc.
Represented By: Siraj M. Abhyankar
Represented By: Carolina Veltri
Represented By: Natalie C. Clayton
Represented By: Dominick T. Gattuso
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Pharmacyclics LLC
Represented By: Maryellen Noreika
Represented By: Jack B. Blumenfeld
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Janssen Biotech, Inc.
Represented By: Maryellen Noreika
Represented By: Jack B. Blumenfeld
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?